Microsoft says its Quine system narrowed thousands of compounds to a pancreatic cancer shortlist in one weekend. For research-AI teams, the part to study is the harness that sends lab results back into the next question, and nobody has yet measured its value across cycles.
Reality
- Evidence35
- Adoption
- Insufficient
- Hype gap+30
- Incentives65
- Confidence40
A Baylor College of Medicine team used a structure-prediction workflow called GluePlex to find where a molecular glue grips the protein VAV1 before any experiment showed it. A separate group later reached the same conclusion in the lab.
Reality
- Evidence72
- Adoption15
- Hype gap+8
- Incentives68
- Confidence62
AbbVie, argenx, Lundbeck and Takeda are founding a Ginkgo and Apheris consortium to build a standardized developability dataset of 10,000 antibodies. Ginkgo will oversee production and wet-lab testing of the whole set, with members due to see the first data in early 2027.
Reality
- Evidence40
- Adoption20
- Hype gap+20
- Incentives65
- Confidence45
The six clocks agreeing matters more than the years they report, because a drug that quiets an inflamed lung moves the same blood proteins whether or not it slows ageing anywhere else.
Perspective Coverage
3 publishers
- Builder
- Builder 45%
- Operator
- Operator 32%
- Investor
- Investor 23%
Reality
- Evidence42
- Adoption5
- Hype gap+45
- Incentives70
- Confidence62
Cellular Intelligence has added Bob Langer and Yann LeCun to its scientific advisory board. The $62m to $70m it has raised now has to take STEM-PD, the cell therapy Novo Nordisk dropped, through Phase 2.
Reality
- Evidence45
- Adoption15
- Hype gap+40
- Incentives65
- Confidence55
S32 led a $140M round that takes Basecamp Research's total funding to $225M since 2019. Two of the sixteen named backers, NVIDIA and Anthropic's Anthology Fund, are also partners on the dataset its models train on.
Perspective Coverage
3 publishers
- Builder
- Builder 30%
- Operator
- Operator 15%
- Investor
- Investor 55%
Reality
- Evidence55
- Adoption
- Insufficient
- Hype gap+40
- Incentives75
- Confidence60
Seventy percent of American adults say they are more worried than excited about AI, and the one exception in the polling is scientific research and medicine. The fastest uptake inside medicine is administrative.
Reality
- Evidence42
- Adoption32
- Hype gap+18
- Incentives38
- Confidence45
The Series C funds a 28-billion-parameter model trained on more than 100 billion genes. Two of the partners who helped assemble that dataset, Nvidia and Anthropic's joint fund, are also in the round.
Reality
- Evidence28
- Adoption
- Insufficient
- Hype gap+34
- Incentives72
- Confidence48
A new paper reports that a model predicting executable atom-level edits outperforms state-of-the-art baselines at generating synthesizable analogues with high structural fidelity, and that open-weight backends perform comparably to proprietary ones.
Reality
- Evidence45
- Adoption15
- Hype gap+20
- Incentives60
- Confidence42
A Melbourne oncologist told the Guardian she doubts a cure for all cancer inside 10 years, and the clinicians who said so expect the real gains in diagnostics, pathology and treatment selection. Those are steps a budget can be written against.
Reality
- Evidence62
- Adoption30
- Hype gap+58
- Incentives55
- Confidence64
UC San Diego researchers treated cancer cells with 25 mitochondria-perturbing compounds, collected 40,000 single-cell 4D movies, and trained a model that sorted the drugs by mechanism with the labels withheld.
Reality
- Evidence62
- Adoption12
- Hype gap+24
- Incentives68
- Confidence55
Life sciences head Eric Kauderer-Abrams confirmed the lab in a Reuters account, describing the split between in-house work and outside partners as ordinary biotech practice, while a spokesperson said the site is not there to discover drugs.
Reality
- Evidence42
- Adoption31
- Hype gap+28
- Incentives68
- Confidence46
The company's head of life sciences told Reuters that real lab work is still the final test in biology. Anthropic has not said which experiments the lab is running, and it has yet to run a clinical trial.
Perspective Coverage
5 publishers
- Builder
- Builder 28%
- Operator
- Operator 35%
- Investor
- Investor 37%
Reality
- Evidence55
- Adoption40
- Hype gap+30
- Incentives70
- Confidence57
The Series A funds a second-generation platform. The only measured result the company has attached to it is a benchmark of its own showing 45% fewer tokens than uncustomized frontier models. Tokens are a compute cost.
Reality
- Evidence32
- Adoption24
- Hype gap+42
- Incentives78
- Confidence60
James Zou's agent company read the results of tens of thousands of finished trials and found that drugs aimed at switch-like, cell-type-specific targets reached market about 48% more often. No experiment has tested that yet.
Reality
- Evidence58
- Adoption22
- Hype gap+32
- Incentives60
- Confidence62
The Danish drugmaker will test Anthropic's science workbench on specific R&D workflows while an earlier company-wide OpenAI agreement keeps running alongside it. Bloomberg reported that financial terms were not disclosed.
Reality
- Evidence52
- Adoption22
- Hype gap+45
- Incentives82
- Confidence58
The Anthropic CEO's September 2026 essay dates the cure of most major disease to roughly 2031 to 2036. He used the same five-to-ten-year width in 2024, when counting from the publication date ended it in 2034.
Reality
- Evidence32
- Adoption
- Insufficient
- Hype gap+68
- Incentives72
- Confidence55
The investor who built Andreessen Horowitz's life-science practice now runs a firm with no associates and AI handling operations, which changes who reads a health founder's deck and how much attrition a single check has to survive.
Reality
- Evidence32
- Adoption18
- Hype gap−10
- Incentives72
- Confidence38
A framework called MAP encodes 694,246 mechanistic links over 187,089 drugs, then reports up to 12.3% better zero-shot response prediction. Per drug, that graph averages under four edges.
Reality
- Evidence58
- Adoption
- Insufficient
- Hype gap+26
- Incentives55
- Confidence44
Stanford's April 2026 tests put debate ahead of rival multi-agent designs, and behind a solo agent at matched compute. The comparison a framework vendor quotes is the first one.
Reality
- Evidence30
- Adoption16
- Hype gap
- Insufficient
- Incentives
- Insufficient
- Confidence32
Earlier coverage
- Insilico credits its AI with a drug discovery. The patent credits five humans.
Product · August 21, 2026 · 1 publisher
- An 'exercise pill' clears Phase I: 88 healthy adults, no GI trouble, no efficacy yet
Product · August 19, 2026 · 1 publisher
- Anthropic's protein binders got tested by outside labs. The benchmark is still Anthropic's.
Product · August 19, 2026 · 1 publisher
- Vivodyne is spending venture money on wet-lab throughput, not bigger models
Build · August 19, 2026 · 2 publishers
- Vivodyne says the AI drug bottleneck is human tissue data, not model capability
Product · August 19, 2026 · 1 publisher
- The judge is the product: building the scorer for an AI malaria drug leaderboard
Build · August 14, 2026 · 1 publisher